DSM-Firmenich AG
DSFIR.AS · AMS
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.78 | -0.05 | -0.93 | 0.25 |
| FCF Yield | 3.92% | 3.34% | 1.37% | 4.88% |
| EV / EBITDA | 50.75 | 28.76 | 15.73 | 25.51 |
| Quality | ||||
| ROIC | 1.21% | -1.57% | 3.57% | 4.90% |
| Gross Margin | 33.17% | 24.57% | 33.15% | 36.59% |
| Cash Conversion Ratio | 7.11 | 0.59 | 2.01 | 0.85 |
| Growth | ||||
| Revenue 3-Year CAGR | 15.12% | -2.44% | 1.15% | 12.68% |
| Free Cash Flow Growth | 42.82% | 154.48% | -71.93% | -4.05% |
| Safety | ||||
| Net Debt / EBITDA | 4.66 | 2.89 | 0.24 | 1.79 |
| Interest Coverage | 3.02 | -3.07 | 10.18 | 3.81 |
| Efficiency | ||||
| Inventory Turnover | 2.60 | 2.36 | 2.40 | 3.16 |
| Cash Conversion Cycle | 120.78 | 148.11 | 125.99 | 88.18 |